247 related articles for article (PubMed ID: 36996070)
1. Novel carbon skeletons activate human NicotinAMide Phosphoribosyl Transferase (NAMPT) enzyme in biochemical assay.
Almeida KH; Avalos-Irving L; Berardinelli S; Chauvin K; Yanez S
PLoS One; 2023; 18(3):e0283428. PubMed ID: 36996070
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Allosteric Modulation of Nicotinamide Phosphoribosyltransferase to Elevate Cellular NAD
Ratia KM; Shen Z; Gordon-Blake J; Lee H; Laham MS; Krider IS; Christie N; Ackerman-Berrier M; Penton C; Knowles NG; Musku SR; Fu J; Velma GR; Xiong R; Thatcher GRJ
Biochemistry; 2023 Feb; 62(4):923-933. PubMed ID: 36746631
[TBL] [Abstract][Full Text] [Related]
3. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells.
Sociali G; Grozio A; Caffa I; Schuster S; Becherini P; Damonte P; Sturla L; Fresia C; Passalacqua M; Mazzola F; Raffaelli N; Garten A; Kiess W; Cea M; Nencioni A; Bruzzone S
FASEB J; 2019 Mar; 33(3):3704-3717. PubMed ID: 30514106
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
[TBL] [Abstract][Full Text] [Related]
5. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity.
Houry D; Raasakka A; Ferrario E; Niere M; Bifulco E; Kursula P; Ziegler M
J Struct Biol; 2023 Sep; 215(3):108004. PubMed ID: 37495196
[TBL] [Abstract][Full Text] [Related]
6. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death.
Velma GR; Krider IS; Alves ETM; Courey JM; Laham MS; Thatcher GRJ
J Med Chem; 2024 Apr; 67(8):5999-6026. PubMed ID: 38580317
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Optimization, and Structure-Activity Relationships of Nicotinamide Phosphoribosyltransferase (NAMPT) Positive Allosteric Modulators (N-PAMs).
Shen Z; Ratia K; Krider I; Ackerman-Berrier M; Penton C; Musku SR; Gordon-Blake JM; Laham MS; Christie N; Ma N; Fu J; Xiong R; Courey JM; Velma GR; Thatcher GRJ
J Med Chem; 2023 Dec; 66(24):16704-16727. PubMed ID: 38096366
[TBL] [Abstract][Full Text] [Related]
8. NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair.
Wang P; Li WL; Liu JM; Miao CY
J Cardiovasc Pharmacol; 2016 Jun; 67(6):474-81. PubMed ID: 26485210
[TBL] [Abstract][Full Text] [Related]
9. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.
Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V
J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide adenine dinucleotide (NAD+): essential redox metabolite, co-substrate and an anti-cancer and anti-ageing therapeutic target.
Griffiths HBS; Williams C; King SJ; Allison SJ
Biochem Soc Trans; 2020 Jun; 48(3):733-744. PubMed ID: 32573651
[TBL] [Abstract][Full Text] [Related]
11. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening.
Ozgencil F; Eren G; Ozkan Y; Guntekin-Ergun S; Cetin-Atalay R
Bioorg Med Chem; 2020 Jan; 28(1):115217. PubMed ID: 31818629
[TBL] [Abstract][Full Text] [Related]
12. Both gain and loss of Nampt function promote pressure overload-induced heart failure.
Byun J; Oka SI; Imai N; Huang CY; Ralda G; Zhai P; Ikeda Y; Ikeda S; Sadoshima J
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H711-H725. PubMed ID: 31347918
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
[TBL] [Abstract][Full Text] [Related]
14. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives.
Wen F; Gui G; Wang X; Ye L; Qin A; Zhou C; Zha X
Bioorg Med Chem; 2024 Feb; 99():117595. PubMed ID: 38244254
[TBL] [Abstract][Full Text] [Related]
15. AMPK phosphorylates NAMPT to regulate NAD
Liao X; Huang X; Li X; Qiu X; Li M; Liu R; He T; Tang Q
Open Biol; 2022 Oct; 12(10):220213. PubMed ID: 36196536
[TBL] [Abstract][Full Text] [Related]
16. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD
Grolla AA; Miggiano R; Di Marino D; Bianchi M; Gori A; Orsomando G; Gaudino F; Galli U; Del Grosso E; Mazzola F; Angeletti C; Guarneri M; Torretta S; CalabrĂ² M; Boumya S; Fan X; Colombo G; Travelli C; Rocchio F; Aronica E; Wohlschlegel JA; Deaglio S; Rizzi M; Genazzani AA; Garavaglia S
J Biol Chem; 2020 Mar; 295(11):3635-3651. PubMed ID: 31988240
[TBL] [Abstract][Full Text] [Related]
17. NAMPT: A critical driver and therapeutic target for cancer.
Gasparrini M; Audrito V
Int J Biochem Cell Biol; 2022 Apr; 145():106189. PubMed ID: 35219878
[TBL] [Abstract][Full Text] [Related]
18. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into Xanthomonas campestris pv. campestris NAD
Xu G; Ma J; Fang Q; Peng Q; Jiao X; Hu W; Zhao Q; Kong Y; Liu F; Shi X; Tang DJ; Tang JL; Ming Z
Commun Biol; 2024 Mar; 7(1):255. PubMed ID: 38429435
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
Dalamaga M
Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]